News from the 12th European Headache Federation Congress
Florence, Italy, 28-30 September 2018
CGRP hypersensitivity may predict anti-CGRP treatment responders
Patients who respond well to erenumab are highly susceptible to CGRP provocation, according to results of a small study to explore a possible correlation between individual efficacy of anti-CGRP treatment and susceptibility to migraine induction by CGRP.
Read the full report here »
Galcanezumab equally effective for low- and high-frequency episodic migraine
Treatment effects of both doses of galcanezumab in reducing monthly migraine headache days and disability and improving function are similar for patients with low- and high-frequency episodic migraine, according to an analysis of pooled data from the EVOLVE-1 and EVOLVE-2 studies.
Read the full report here »
DNA methylation study sheds new light on CGRP gene involvement in migraine
Preliminary data suggest that DNA methylation of part of the promoter region of the CALCA gene which encodes CGRP is different in patients with migraine, compared to those who do not have the disease.
Read the full report here »
Fremanezumab data confirm efficacy in patients with previous prophylaxis failure
Fremanezumab has been shown to improve multiple efficacy parameters in patients who failed at least one previous preventive medication, including monthly migraine days, need for acute migraine medication and disability, in a series of analyses of Phase 3 trials in episodic and chronic migraine.1-3
Read the full report here »
CGRP study highlights potential mechanistic differences between episodic and chronic cluster headache
A new investigation of levels of CGRP, vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide-38 (PACAP-38) in patients with episodic and cluster headache has suggested basic pathophysiological differences between the two conditions.1
Read the full report here »
Neck pain is more likely a symptom of migraine than a trigger
Neck pain/tension is more likely to be a symptom of migraine than a trigger, according to digital diary data from 774 patients with migraine who recorded their headaches along with information about potential contributory factors.
Read the full report here »
Excessive yawning linked to increased migraine risk in a quarter of patients
Excessive yawning could be used as an early warning for migraine attacks in susceptible individuals and enable rapid intervention, conclude the authors of a study investigating this common premonitory migraine symptom.
Read the full report here »
| Becoming a member is easy
Members have free open access simply by registering online. | |
